2008 BIO comes to a close

Well, as the BIO 2008 International Convention draws to a close we can say that this has been one of the best shows ever. We ended up with 20,108 industry leaders from 70 different countries and 48 states.
The full Convention program included four full days with 175 breakout sessions, 21 educational tracks, more than 1,000 [...]

Thank you

As this year’s convention draws to a close, we’d like to stop and take a moment and thank all the people that made our foray into social media a success.
Thanks to all the bloggers on BIO on the road, who reported their experiences as they happened. Thanks to the members of the BIO2008 Twitter [...]

AR Post: Forest City Enterprises – Building Colorado Bio Park

If you are resident at MIT, Hopkins, UPenn, Northwestern or the University of Chicago you are likely intimately aware of the name Forest City Enterprises, Booth 5508. That is because the Forest City Science + Technology Group, recognized as one of the country’s leading developers & owners of life science campuses, has completed your shiny [...]

Ernst & Young 2008 Global biotechnology report highlights

The Bio International Convention hosted a fantastic panel today on the 2008 Ernst & Young global biotechnology report.  The industry is at “the start of a revolution” and aiming to reinvent itself because of three trends, shared moderator Glen Giovannetti of Ernst & Young, (1) R&D productivity, (2) personalized medicine, and (3) globalization.  This post [...]

Raising PKU awareness

Following Wednesday’s Keynote Luncheon, Governor Arnold Schwarzenegger of California met with John Adams Jr., a Phenylketonuria (PKU) patient who was diagnosed with the disease as a newborn.
PKU is an inherited metabolic disorder that causes problems with brain development, leading to progressive mental retardation and seizures.
Adam’s father currently serves as the President & CEO of the [...]

State of the Industry

Steven Burrill, CEO of Burrill and Company, presented the “State-of-the-Industry” to a packed ballroom yesterday. Burrill made his prediction about where health care will be in 2020: more emphasis on the wellness of society rather than sickness by implementing genetic screening.  Said Burrill, “We’re moving health care to the patient, which will lead to more specialized [...]

What’s Happening Across the Country for Biotech?

All the indicators say, grow, grow, grow in the new report, Technology, Talent and Capital: State Bioscience Initiatives 2008, released today at the BIO International Convention.
Some highlights:
total U.S. employment in the biosciences reached 1.3 million in 2006, up from 1.2 million in 2004,
led by strong growth in the research, testing and medical lab subsector, which experienced a [...]

Gov Patrick Will Be Coming to BIO Just Having Signed Ground-Breaking Legislation

As many of you know Gov. Patrick is to be honored as BIO’s Governor of the year in a few days.  Well today, he showed us why by signing the Massachusetts Life Sciences Law.  
The 10-year $1 billion investment package is the result of a year-long collaboration between the Governor, the Legislature, academia, life sciences industry [...]

MA Governor Deval Patrick to be Honored as BIO Governor of the Year

WHAT:
The Biotechnology Industry Organization (BIO) will present Massachusetts Governor Deval Patrick with its Governor of the Year award in recognition of his leadership and support of the biosciences industry.
WHEN:
Tuesday, June 17, 2008, at 11:45 a.m. PDT
WHERE:
BIO 2008 International Convention
San Diego Convention Center
Upper Level, Ballroom 20
WHO:
Joshua Boger, PhD, Chairman of BIO’s Board of Directors and President [...]

BIO and Battelle to Present State-By-State Analysis of Bioscience Trends

WHAT: A comprehensive state-by-state analysis of bioscience initiatives in all 50 states and Puerto Rico. The report uses the most current and comparable annual data available to present national, state and metropolitan bioscience employment and growth trends. The report also examines other indicators of a state’s bioscience industry including R&D funding, venture capital investment, and [...]